AMENDED & RESTATED EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • March 13th, 2009 • Seattle Genetics Inc /Wa • Biological products, (no disgnostic substances) • Washington
THIS AMENDED & RESTATED EXECUTIVE EMPLOYMENT AGREEMENT (“Agreement”) is made and entered into as of the 15th day of December, 2008, by and between SEATTLE GENETICS, INC., a Delaware corporation (“Company”) and Clay B. Siegall (“Executive”).
Consulting AgreementConsulting Agreement • March 13th, 2009 • Seattle Genetics Inc /Wa • Biological products, (no disgnostic substances) • California
This Consulting Agreement (the “Agreement”) is between Hoth Consulting Inc., (“HCI”), with offices at 2240 Green St, Suite 5, San Francisco CA 94123 and Seattle Genetics, Inc., having an office at 21823 – 30th Drive Southeast, Bothell, Washington 98021 (“Client”).
AMENDMENT NO. 1 TO OPTION AND LICENSE AGREEMENTOption and License Agreement • March 13th, 2009 • Seattle Genetics Inc /Wa • Biological products, (no disgnostic substances)
This Amendment No. 1 (this “Amendment”) to Option and License Agreement effective as of September 27th, 2004 (the “Amendment Date”) is entered into by and between Sanquin Blood Supply Foundation for the purpose of this Amendment acting through her Research Division, formed under the laws of the Netherlands (“CLB”), and Seattle Genetics, Inc., a Delaware corporation (“SGI”).
OPTION and LICENSE AGREEMENTOption and License Agreement • March 13th, 2009 • Seattle Genetics Inc /Wa • Biological products, (no disgnostic substances) • Washington
This Option and License Agreement (this “Agreement”), is entered into as of July 5, 2001 (the “Effective Date”) by and between Sanquin Blood Supply Foundation for the purpose of this agreement acting through her division CLB-Research and Development, formed under the laws of the Netherlands (hereinafter referred to as “CLB”) and Seattle Genetics, Inc., a Delaware corporation (hereinafter referred to as “SGI”).
SEATTLE GENETICS, INC. STOCK OPTION AGREEMENTStock Option Agreement • March 13th, 2009 • Seattle Genetics Inc /Wa • Biological products, (no disgnostic substances) • Delaware
THIS STOCK OPTION AGREEMENT (the “Agreement”) dated [GRANT DATE] (“Grant Date”) between Seattle Genetics, Inc., a Delaware corporation (the “Company”), and [EMPLOYEE NAME] (“Optionee”), is entered into as follows:
